Cargando…
Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167295/ https://www.ncbi.nlm.nih.gov/pubmed/32320742 http://dx.doi.org/10.1016/j.metabol.2020.154245 |
| _version_ | 1783523554374975488 |
|---|---|
| author | Angelidi, Angeliki M. Belanger, Matthew J. Mantzoros, Christos S. |
| author_facet | Angelidi, Angeliki M. Belanger, Matthew J. Mantzoros, Christos S. |
| author_sort | Angelidi, Angeliki M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7167295 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71672952020-04-20 Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next Angelidi, Angeliki M. Belanger, Matthew J. Mantzoros, Christos S. Metabolism Article Elsevier Inc. 2020-06 2020-04-19 /pmc/articles/PMC7167295/ /pubmed/32320742 http://dx.doi.org/10.1016/j.metabol.2020.154245 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Angelidi, Angeliki M. Belanger, Matthew J. Mantzoros, Christos S. Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next |
| title | Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next |
| title_full | Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next |
| title_fullStr | Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next |
| title_full_unstemmed | Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next |
| title_short | Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next |
| title_sort | commentary: covid-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167295/ https://www.ncbi.nlm.nih.gov/pubmed/32320742 http://dx.doi.org/10.1016/j.metabol.2020.154245 |
| work_keys_str_mv | AT angelidiangelikim commentarycovid19anddiabetesmellituswhatweknowhowourpatientsshouldbetreatednowandwhatshouldhappennext AT belangermatthewj commentarycovid19anddiabetesmellituswhatweknowhowourpatientsshouldbetreatednowandwhatshouldhappennext AT mantzoroschristoss commentarycovid19anddiabetesmellituswhatweknowhowourpatientsshouldbetreatednowandwhatshouldhappennext |